Aradi D - Search Results

1

Cangrelor infusion is associated with an increased risk for bleeding: meta-analysis of randomized trials.

Serebruany VL, Aradi D, Kim MH, Sibbing D. Serebruany VL, et al. Among authors: aradi d. Int J Cardiol. 2013 Nov 5;169(3):225-8. doi: 10.1016/j.ijcard.2013.08.133. Epub 2013 Sep 7. Int J Cardiol. 2013. PMID: 24071381

2

The in vitro effects of niacin on platelet biomarkers in human volunteers.

Serebruany V, Malinin A, Aradi D, Kuliczkowski W, Norgard NB, Boden WE. Serebruany V, et al. Among authors: aradi d. Thromb Haemost. 2010 Aug;104(2):311-7. doi: 10.1160/TH10-01-0015. Epub 2010 Jun 10. Thromb Haemost. 2010. PMID: 20539903

3

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL. Aradi D, et al. Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Am Heart J. 2010. PMID: 20826265 Review.

4

Outcomes of patients receiving clopidogrel prior to cardiac surgery.

Vorobcsuk A, Aradi D, Farkasfalvi K, Horváth IG, Komócsi A. Vorobcsuk A, et al. Among authors: aradi d. Int J Cardiol. 2012 Apr 5;156(1):34-40. doi: 10.1016/j.ijcard.2010.10.034. Epub 2010 Nov 26. Int J Cardiol. 2012. PMID: 21112646 Review.

5

Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel.

Aradi D, Kuliczkowski W, Atar D, Serebruany VL. Aradi D, et al. Thromb Haemost. 2012 Feb;107(2):338-45. doi: 10.1160/TH11-09-0622. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186910

6

Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.

Reny JL, Combescure C, Daali Y, Fontana P; PON1 Meta-Analysis Group. Reny JL, et al. J Thromb Haemost. 2012 Jul;10(7):1242-51. doi: 10.1111/j.1538-7836.2012.04756.x. J Thromb Haemost. 2012. PMID: 22520065 Free PMC article. Review.

7

Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Price MJ, Cuisset T, Ari H, Hazarbasanov D, Trenk D, Sibbing D, Valgimigli M, Bonello L; Tailored Antiplatelet Treatment Study Collaboration. Aradi D, et al. Int J Cardiol. 2013 Sep 1;167(5):2140-8. doi: 10.1016/j.ijcard.2012.05.100. Epub 2012 Jun 15. Int J Cardiol. 2013. PMID: 22704866 Review.

8

Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Serebruany VL. Aradi D, et al. Thromb Haemost. 2013 Jan;109(1):93-101. doi: 10.1160/TH12-06-0377. Epub 2012 Nov 29. Thromb Haemost. 2013. PMID: 23197191 Review.

9

Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment.

Aradi D, Sibbing D, Bonello L. Aradi D, et al. Int J Cardiol. 2013 Sep 1;167(5):1794-7. doi: 10.1016/j.ijcard.2012.12.026. Epub 2013 Jan 3. Int J Cardiol. 2013. PMID: 23290951 Review.

10

Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial.

Serebruany VL, Pokov AN, Aradi D, Can M, DiNicolantonio J, Kipshidze N, Atar D. Serebruany VL, et al. Among authors: aradi d. Am J Ther. 2014 Nov-Dec;21(6):482-90. doi: 10.1097/MJT.0b013e31826915ab. Am J Ther. 2014. PMID: 23698186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters